UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
May 11, 2006 (May 11, 2006)
_______________
DIALYSIS CORPORATION OF AMERICA
(Exact name of registrant as specified in its charter)
Florida 0-8527 59-1757642
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1302 Concourse Drive, Suite 204, Linthicum, MD 21090
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (410) 694-0500
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On May 11, 2006, Dialysis Corporation of America issued a press release
announcing its financial results for the quarter ended March 31, 2006. A
copy of the May 11, 2006 press release is attached as an exhibit to this
Current Report and is incorporated herein by reference.
The information furnished pursuant to Item 2.02, including the Exhibit
(99)(i), shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
(99) Additional exhibits
(i) Press Release dated May 11, 2006.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DIALYSIS CORPORATION OF AMERICA
/s/ Stephen W. Everett
By-----------------------------------
STEPHEN W. EVERETT
President and Chief Executive
Officer
Dated: May 11, 2006
EXHIBIT INDEX
Exhibit
Number
--------
(99)(i) Press Release dated May 11, 2006.
JAFFE & FALK, LLC
777 Terrace Avenue
Hasbrouck Heights, NJ 07604
Telephone: (201) 288-8282
Facsimile: (201) 288-8208
Email: jmj@jaffefalkllc.com
May 11, 2006
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
RE: Dialysis Corporation of America Current Report on Form 8-K
Commission File No. 0-8527
Gentlemen:
Enclosed for filing pursuant to the EDGAR system is the aforementioned
company's Current Report on Form 8-K and exhibit, pursuant to the
requirements of the Securities Exchange Act of 1934.
Very truly yours,
JAFFE & FALK, LLC
/s/ Joshua M. Jaffe
By:--------------------------------
Joshua M. Jaffe
JMJ:naf
Enclosure
cc: Nasdaq Stock Market, Inc.